However, it has also been reported that tumor treatment by inhibiting the PD-1/PD-L1 signaling pathway was likely to cause immune imbalance, resulting in autoimmune diseases, such as multiple sclerosis, inflammatory bowel disease, Hashimoto’s thyroiditis, and rheumatoid arthritis (19, 20). Here, CD274 is linked to neoplasm.